Strategic Minority Investment Company MiNA Therapeutics Enters Into Collaboration and Licensing Agreement With Boehringer Ingelheim
Sosei Group Corporation (‘Sosei’; TSE Mothers Index 4565), is pleased to note that our strategic minority investment company MiNA Therapeutics ('MiNA') has announced a collaboration and licensing agreement with the global pharmaceutical company Boehringer Ingelheim for the development of novel treatment approaches for fibrotic liver diseases.
Under the terms of the agreement, MiNA will receive an upfront payment and committed research funding as well as potential research, development and regulatory milestone payments totaling up to EUR 307 million. In addition, MiNA is entitled to double-digit royalties on sales of selected products resulting from the partnership. No further financial details were disclosed.
Commenting on the release, Peter Bains, CEO at Sosei, said: “We are very encouraged by this agreement, which is MiNA’s first ever major collaboration and reinforces its leading position in small activating RNA (‘saRNA’) therapeutics. Furthermore, we believe it represents a strong validation of the broad potential for its proprietary technology.”
Click here for link to the full press release from MiNA Therapeutics and Boehringer Ingelheim
About Sosei Group Corporation
Sosei Group Corporation is an international biopharmaceutical company originating from Japan that discovers and develops innovative biopharmaceuticals for the treatment of Alzheimer's disease, schizophrenia, cancer, migraine, addiction, metabolic disease, and other indications. By utilizing its GPCR structure-based drug design platform technology, Sosei has established a product pipeline with first/best in class potential. Through development and commercialization partnerships, Sosei has already delivered two bronchodilators for COPD which generate significant and stable revenue streams that enable further growth. Sosei partners include Novartis, Allergan, AstraZeneca, MedImmune, MorphoSys, Teva, and Pfizer and we are actively looking for new partnerships to enhance the development of our products and help us deliver them to patients worldwide.
For further information about Sosei, please visit http://www.sosei.com/en/ .
This press release contains forward-looking statements, including statements about the discovery, development and commercialisation of products. Various risks may cause Sosei’s actual results to differ materially from those expressed or implied by the forward-looking statements, including: adverse results in clinical development programmes; failure to obtain patent protection for inventions; commercial limitations imposed by patents owned or controlled by third parties; dependence upon strategic alliance partners to develop and commercialise products and services; difficulties or delays in obtaining regulatory approvals to market products and services resulting from development efforts; the requirement for substantial funding to conduct research and development and to expand commercialisation activities; and product initiatives by competitors. As a result of these factors, prospective investors are cautioned not to rely on any forward-looking statements. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise .
Sosei Group Corporation
Chris Cargill, +44-(0)7912-892-199
Head of Investor Relations and Corporate Communications
Harumi Banse, +81-(0)3-5210-3399
Investor Relations and Corporate Communications
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
JPMORGAN-CHASE17.7.2018 21:42 | pressemeddelelse
JPMorgan Chase Bank announces the placement of cash-settled exchangeable bonds into Ping An Insurance (Group) Company of China Limited due 2020
MA-BOSTON-CAPITAL17.7.2018 16:02 | pressemeddelelse
Boston Capital Announces Closing of Boston Capital Income & Value U.S. Apartment Fund
CA-AMOBEE17.7.2018 15:15 | pressemeddelelse
Amobee Wins Auction Process to Acquire Videology Assets
JPMORGAN-CHASE17.7.2018 14:02 | pressemeddelelse
JPMorgan Chase Bank launches offering of cash-settled exchangeable bonds into Ping An Insurance (Group) Company of China Limited due 2020
NC-LENOVO17.7.2018 14:02 | pressemeddelelse
Lenovo Leaps Forward with Next-Generation ThinkAgile Composable Cloud Platform
PA-GREENE-TWEED17.7.2018 13:03 | pressemeddelelse
Greene Tweed Achieves Nadcap Accreditation for Non-Metallic Materials Testing
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum